Vectus Biosystems (ASX:VBS) Other Long Term Assets

: A$-0.00 Mil (As of Dec. 2022)

View and export this data going back to 2016. Start your Free Trial

Vectus Biosystems's other long-term assets for the quarter that ended in Dec. 2022 was A$-0.00 Mil.

Vectus Biosystems's quarterly other long-term assets declined from Dec. 2021 (A$0.00 Mil) to Jun. 2022 (A$-0.00 Mil) but then increased from Jun. 2022 (A$-0.00 Mil) to Dec. 2022 (A$-0.00 Mil).

Vectus Biosystems's annual other long-term assets increased from Jun. 2020 (A$0.00 Mil) to Jun. 2021 (A$0.00 Mil) but then declined from Jun. 2021 (A$0.00 Mil) to Jun. 2022 (A$-0.00 Mil).

Vectus Biosystems Other Long Term Assets Historical Data

The historical data trend for Vectus Biosystems's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Other Long Term Assets

Vectus Biosystems Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Other Long Term Assets										-	-	-	-	-

Vectus Biosystems Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Vectus Biosystems (ASX:VBS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018

Website

http://www.vectusbiosystems.com.au

Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines